Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Buy
+11,643
New +$305K 0.02% 254
2023
Q2
Sell
-14,788
Closed -$603K 462
2023
Q1
$603K Buy
14,788
+548
+4% +$23.7K 0.04% 187
2022
Q4
$730K Buy
14,240
+2,036
+17% +$97.6K 0.07% 159
2022
Q3
$534K Sell
12,204
-429
-3% -$20.8K 0.05% 184
2022
Q2
$663K Buy
+12,633
New +$644K 0.05% 171

Other funds holding PFE

American Trust's PFE Position: Q2 2026 in Review

American Trust opened a new position in Pfizer (PFE) in Q2 2026: 11,643 shares worth $280K. The stake represents 0.02% of the portfolio and ranks #254 among its holdings. This is a return to the name: American Trust previously reported a position in PFE as recently as Q1 2023.

American Trust first reported a position in PFE in Q2 2022 and has held it in 5 quarters since. The position peaked at $730K in Q4 2022. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • American Trust held 11,643 shares of Pfizer worth $280K as of Q2 2026.
  • Pfizer was a new American Trust position in Q2 2026.
  • Pfizer made up 0.02% of American Trust's portfolio in Q2 2026, its #254 holding.
  • American Trust first reported a position in Pfizer in Q2 2022 and has held it in 5 quarters since.
  • American Trust's Pfizer position peaked at $730K in Q4 2022.
  • 2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.